Physician profile
Neil Page
NPI 1073591152
$628.03
in general payments reported to CMS, 2019-2025
13 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.78 · 2023: $133 · 2024: $134 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $159.70 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $91.38 | 2023-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $75.91 | 2023-2025 | Shingrix, Arexvy, Penmenvy |
| Exact Sciences Corporation | $74.89 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Intuitive Surgical, INC. | $51.61 | 2024 | |
| Indivior INC. | $32.87 | 2025 | Sublocade |
| Irhythm Technologies, INC. | $23.56 | 2024 | Zio Monitor, Zio Xt Patch |
| Abbvie INC. | $23.06 | 2022 | |
| Pfizer INC. | $22.72 | 2022 | |
| Inspire Medical Systems, INC. | $22.12 | 2025 | Inspire |
| Amgen INC. | $18.97 | 2023 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals Lp | $16.36 | 2025 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.88 | 2023 | Tradjenta, Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.